Directorate Change
30 January 2024
Halma, the FTSE 100 global group of life-saving technology companies, today announces the appointment of Giles Kerr as an independent non-executive Director, with effect from 1 February 2024. Giles will also be a member of Halma’s Audit, Remuneration and Nomination Committees.
Giles brings a wealth of experience gained across a variety of roles in life sciences, technology and industrial businesses. Giles has a particularly strong background in driving strategic business growth as well as extensive M&A experience. He is currently Chair of PayPoint plc and was Senior Independent Director & Audit Committee Chair at Abcam plc, until it was acquired by Danaher in December 2023.
His executive career included senior financial roles at Arthur Andersen (leading to his appointment as National Partner), Amersham plc (latterly as Group Finance Director) and as Finance Director at Oxford University Innovation. Since 2007, Giles has held a number of non-executive director roles including Elan Corporation, Victrex plc, BTG plc, Oxford Sciences Innovation plc, Arix Bioscience plc and Senior plc.
Roy Twite, non-executive Director, who has served for nine years on the Board, will step down as a Director on 7 June 2024.
Dame Louise Makin, Chair, commented: “I am delighted that Giles is joining the Halma Board. His extensive executive and non-executive experience, particularly in the life sciences and technology sectors, will bring valuable insights and perspectives to the Board.
I would like to thank Roy for his valuable contribution to Halma, and particularly the support that he has given to me and the Board to ensure an orderly transition and onboarding of recent executive and non-executive Directors”
There are no further details to be disclosed for Giles Kerr under Listing Rule 9.6.13R.
For further information, please contact:
Halma plc
Marc Ronchetti, Group Chief Executive
Steve Gunning, Group Chief Financial Officer
Charles King, Head of Investor Relations +44 (0) 7776 685948
Clayton Hirst, Director of Corporate Affairs +44 (0) 7384 796 013
MHP
Oliver Hughes / Rachel Farrington / Ollie Hoare +44 (0)20 3128 8100
A copy of this announcement, together with other information about Halma, is available at www.halma.com.
About Halma
Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad markets it operates in:
- Safety – Protecting people’s safety and the environment as populations grow, and enhancing worker safety.
- Environment – Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research.
- Health – Meeting the increasing demand for better healthcare as chronic illness rises, driven by growing and ageing populations and lifestyle changes.
It employs over 8,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100 index.
Halma has been named as one of Britain’s Most Admired Companies for the past five years.
